<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03612557</url>
  </required_header>
  <id_info>
    <org_study_id>B8441001</org_study_id>
    <nct_id>NCT03612557</nct_id>
  </id_info>
  <brief_title>A Study of Benzathine Benzylpenicillin Intramuscular Injection in Japanese Healthy Subjects</brief_title>
  <official_title>A Phase 1, Open-label Study To Investigate The Pharmacokinetics And Safety Of A Single Intramuscular Injection Of Benzathine Benzylpenicillin In Japanese Healthy Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pfizer</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pfizer</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This will be an open label study to investigate the pharmacokinetics (PK) and safety of a
      single intramuscular injection of penicillin G benzathine in Japanese healthy subjects.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 20, 2018</start_date>
  <completion_date type="Actual">October 2, 2018</completion_date>
  <primary_completion_date type="Actual">October 2, 2018</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Maximum observed plasma concentration for penicillin G (Cmax)</measure>
    <time_frame>0, 3, 6, 12, 24, 36, 48, 144, 312, 480, and 648 hours post dose</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Time to Cmax (Tmax)</measure>
    <time_frame>0, 3, 6, 12, 24, 36, 48, 144, 312, 480, and 648 hours post dose</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Area under the plasma concentration time curve from time zero to the time of the last measurable concentration (AUClast)</measure>
    <time_frame>0, 3, 6, 12, 24, 36, 48, 144, 312, 480, and 648 hours post dose</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Area under the plasma concentration time curve from time zero extrapolated to infinite time (as data permit)(AUCinf)</measure>
    <time_frame>0, 3, 6, 12, 24, 36, 48, 144, 312, 480, and 648 hours post dose</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Apparent clearance (as data permit) (CL/F)</measure>
    <time_frame>0, 3, 6, 12, 24, 36, 48, 144, 312, 480, and 648 hours post dose</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Apparent volume of distribution (as data permit) (Vz/F)</measure>
    <time_frame>0, 3, 6, 12, 24, 36, 48, 144, 312, 480, and 648 hours post dose</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Terminal half life (as data permit) (t1/2)</measure>
    <time_frame>0, 3, 6, 12, 24, 36, 48, 144, 312, 480, and 648 hours post dose</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Subjects experiencing an Adverse Event</measure>
    <time_frame>Screening up to 28 days after last dose of study medication</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">8</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>active treatment arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>penicillin G benzathine treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>penicillin G benzathine</intervention_name>
    <description>2.4 million units (IM) of benzathine benzylpenicillin</description>
    <arm_group_label>active treatment arm</arm_group_label>
    <other_name>penicillin G</other_name>
    <other_name>benzathine benzylpenicillin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy female subjects (of childbearing or nonchildbearing potential) and/or male
             subjects

          -  Body mass index (BMI) of 17.5 to 30.5 kg/m2; and a total body weight &gt;50 kg and &lt;100
             kg.

        Exclusion Criteria:

        â€¢ Evidence or history of clinically significant hematological, renal, endocrine, pulmonary,
        gastrointestinal, cardiovascular, hepatic, psychiatric, neurological, or allergic disease
        (history of penicillin hypersensitivity and/or a history of sensitivity to allergens).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pfizer CT.gov Call Center</last_name>
    <role>Study Director</role>
    <affiliation>Pfizer</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>P-one Clinic, Keikokai Medical Corporation</name>
      <address>
        <city>Hachioji-shi</city>
        <state>Tokyo</state>
        <zip>192-0071</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <link>
    <url>https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=B8441001&amp;StudyName=A+Phase+1%2C+Open-label+Study+To+Investigate+The+Pharmacokinetics+And+Safety+Of+A+Single+Intramuscular+Injection+Of+2%2C400%2C000+Units+Penicillin+G+Benzathine+In+Japanese+Healthy+Subjects</url>
    <description>To obtain contact information for a study center near you, click here.</description>
  </link>
  <link>
    <url>https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=B8441001&amp;StudyName=A+Phase+1%2C+Open-label+Study+To+Investigate+The+Pharmacokinetics+And+Safety+Of+A+Single+Intramuscular+Injection+Of+Benzathine+Benzylpenicillin+In+Japanese+Healthy+Subjects</url>
    <description>To obtain contact information for a study center near you, click here.</description>
  </link>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>July 27, 2018</study_first_submitted>
  <study_first_submitted_qc>July 27, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 2, 2018</study_first_posted>
  <last_update_submitted>October 8, 2018</last_update_submitted>
  <last_update_submitted_qc>October 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 10, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Benzathine benzylpenicillin</keyword>
  <keyword>penicillin G benzathine</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Penicillins</mesh_term>
    <mesh_term>Penicillin G</mesh_term>
    <mesh_term>Penicillin G Benzathine</mesh_term>
    <mesh_term>Penicillin G Procaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Information relating to our policy on data sharing and the process for requesting data can be found at the following link: http://www.pfizer.com/research/clinical_trials/trial_data_and_results/data_requests</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

